Navigation Links
Perot Systems Announces Name Change of JJWild
Date:11/7/2008

re capabilities enables us to better serve the MEDITECH community," said Berk Smith, Executive Vice President for Perot Systems' healthcare group and global leader of the MEDITECH Solutions Group within Perot Systems. "The acquisition has allowed us to broaden our offerings to include new products and services like MSite MEDITECH Hosting Solution and expanding clinical transformation services. This, in addition to our long-standing offerings such as MEDITECH application optimization, technology integration, and our JSite disaster recovery service, has enabled us to build a broad portfolio of offerings that will be extremely valuable for our MEDITECH clients," stated Smith.

For more information on the MEDITECH Solutions Group within Perot Systems, please visit http://www.perotsystems.com/meditech.

About Perot Systems

Perot Systems is a worldwide provider of information technology services and business solutions. Through its flexible and collaborative approach, Perot Systems integrates expertise from across the company to deliver custom solutions that enable clients to accelerate growth, streamline operations and create new levels of customer value. Headquartered in Plano, Texas, Perot Systems reported 2007 revenue of $2.6 billion. The company has more than 23,000 associates located in the Americas, Europe, Middle East and Asia Pacific. Additional information on Perot Systems is available at http://www.perotsystems.com.

This press release contains forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. For factors that could affect our business and cause actual results to differ materially, please refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2007, as fi
'/>"/>

SOURCE Perot Systems Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Perot Systems Successfully Implements Hospital Information System in Abu Dhabi
2. Photos: Perot Systems Expands Healthcare Market Initiatives with Launch of Revenue Cycle Solutions Ad Campaign
3. New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software
4. Perot Systems and Sinai Health System Extend Revenue Cycle Solutions Contract
5. Harvard Pilgrim Health Care and Perot Systems Named as Best Partnership by Outsourcing Center
6. Perot Systems Announces the Launch of Xcelys(TM) 5.0 Software
7. Perot Systems Ranked #1 for Clinical Implementation Services By KLAS
8. Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions
9. Perot Systems Selected to Implement Revenue Cycle Solution for New York Downtown Hospital
10. Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship
11. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Reinberg HealthDay Reporter FRIDAY, ... should reassure the millions of American women who have migraine: ... "There is no association between migraine and breast cancer ... medicine at Harvard Medical School. "There is no positive association, ... no protective effect either." About 18 percent of American ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss ... which is contributing to the growth in the global audiological ... of hearing loss and balance disorders are known as audiological ... speaker and amplifier. The global market is expected to grow ... period from 2014 to 2019. Some of the factors which ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Emergo Group, ... in 26 countries in North and South America, Europe, ... responses from industry participants for its 2015 Medical Device ... order to identify upcoming business and market trends as ... , The survey targets areas including:, , ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 At the ... organizations AutismOne and Focus Autism ... attendees with research on the effects of toxins to ... and intervention information. , Luminaries such as Dr. ... from abroad with esteemed, credentialed colleagues of the United ...
(Date:12/15/2014)... 2014 Kenmode Precision Metal Stamping has ... Director of Quality Assurance. He brings more than ... and certifications for manufacturers in the U.S. and abroad. ... Quality Manager at Sonoco Products Company in the Protective ... and Quality Assurance Manager for Prince Industries, all in ...
Breaking Medicine News(10 mins):Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2
... vaccine is the first 5-in-1 pediatric combination for, immunization against ... ... b (Hib) -, SWIFTWATER, Pa. and LYON, France, June ... announced today,that the U.S. Food and Drug Administration (FDA) has ...
... AM ET MONDAY JUNE 23, 2008 , LOW SOCIOECONOMIC ... Cancer patients with low socioeconomic status (SES) have more advanced ... higher risk of dying in the five years following cancer ... appear in the August 1, 2008 issue of CANCER ...
... can prevent unnecessary accidents, experts say , , SUNDAY, June ... can greatly reduce the risk of serious head, spinal ... and recreational activities, says the American Association of Neurological ... head injuries treated in U.S. hospital emergency rooms in ...
... under 80, could ease expected worldwide shortfall of supplies , , ... called HBOC-201 proved safe and effective in a six-week Phase ... In all, 688 patients, ages 18 and older, who had ... (about one pint) or an equivalent one unit (65 grams) ...
... earlier treatment options for patients -, ... Millennium,Pharmaceuticals, The Takeda Oncology Company, and ... announced that the U.S. Food,and Drug Administration ... multiple myeloma (MM). The Company,s co-development partner,Johnson ...
... SAN FRANCISCO, June 20 The San Francisco,Medical Society ... in,Medical/Health Reporting." This $1,000 award is presented each ... good work of California reporters,from television, radio and ... 30, 2008 for the 2009 award., A ...
Cached Medicine News:Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 2Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 3Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 4Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 5Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 2Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 3Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 4Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 5Health News:Head Injuries All Too Common in Summer Play 2Health News:Blood Substitute Found Safe in Large Phase III Trial 2Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 2Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 3Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 4Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 5Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 6Health News:SFMS David Perlman Award For Excellence in Medical/Health Reporting Recognizes Local Reporters 2
(Date:12/17/2014)... 2014 Los beneficios y ganancias ... nivel de gasto en investigación y desarrollo   ... 30 de septiembre de 2014) ZEISS aumentó sus ingresos ... euros (año anterior: 4.190 millones de euros) a pesar ... (EBIT) crecieron un 14 por ciento, a 360 millones ...
(Date:12/17/2014)... HOLBROOK, N.Y. , Dec. 17, 2014 /PRNewswire/ ... that The Depository Trust Company (DTC) has made ... the Deposit Chill on the Company,s stock effective ... of Northstar,s common stock for depository and book ... and the Company is now once again fully ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3
... - GenVec, Inc.,(Nasdaq:GNVC) announced today data from ... of the American Association of Cancer,Research (AACR) ... systems,to deliver the gene for tumor necrosis ... (TNFerade),is an adenovector, or DNA carrier, which ...
... 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced the presentation ... trial of the triplet combination of TELCYTA(R),(canfosfamide ... treatment of advanced non-small cell lung cancer. ... in both progression-free survival and overall survival,in ...
Cached Medicine Technology:GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4
... The Cholestech LDX System, using patented, innovative ... glucose and ALT in only 5 minutes ... ALT test, you can get immediate liver ... capabilities is not the only advantage to ...
The Strep A Rapid Test Strip is a rapid chromatographic,immunoassay for the qualitative detection of Strep A antigen,from throat swab specimens to aid in the diagnosis of Group A,Streptococcal ...
SAS Strep A Test is a rapid visual test for the presumptive qualitative detection of Group A Streptococcal antigen from throat swab specimens. Group A streptococcus is the principal cause of respirat...
HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
Medicine Products: